GLP1R and polycystic ovary syndrome: The results illustrate the therapeutic advantages of GLP-1 receptor agonists for women with PCOS and metabolic dysfunction, whereby anovulation and diminished fertility are mostly associated with insulin resistance and hyperandrogenism.